Search Results

There are 62514 results for: content related to: Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening

  1. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  2. You have free access to this content
    Systematic review with meta-analysis: comparison between therapeutic regimens for paediatric chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 1, July 2015, Pages: 12–19, A. El Sherbini, S. Mostafa and E. Ali

    Version of Record online : 30 APR 2015, DOI: 10.1111/apt.13221

  3. Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review

    Journal of Viral Hepatitis

    Volume 20, Issue 9, September 2013, Pages: 593–599, A. Raza, S. Mittal and G. K. Sood

    Version of Record online : 5 AUG 2013, DOI: 10.1111/jvh.12135

  4. Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection

    Journal of Viral Hepatitis

    Volume 19, Issue 6, June 2012, Pages: 387–395, I. Mederacke, C. Yurdaydin, A. Großhennig, A. Erhardt, Y. Cakaloglu, K. Yalcin, S. Gurel, S. Zeuzem, K. Zachou, C. Chatzikyrkou, H. Bozkaya, G. N. Dalekos, M. P. Manns, H. Wedemeyer and on behalf of Hep-Net/International Delta Hepatitis Study Group

    Version of Record online : 19 DEC 2011, DOI: 10.1111/j.1365-2893.2011.01560.x

  5. You have free access to this content
    Review article: investigational agents for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 29, Issue 7, April 2009, Pages: 689–705, A. J. V. THOMPSON and J. G. MCHUTCHISON

    Version of Record online : 17 JAN 2009, DOI: 10.1111/j.1365-2036.2009.03927.x

  6. You have free access to this content
    Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon

    Liver International

    Volume 30, Issue 5, May 2010, Pages: 657–668, Patrick Marcellin, Joseph Sung and Teerha Piratvisuth

    Version of Record online : 15 FEB 2010, DOI: 10.1111/j.1478-3231.2010.02207.x

  7. You have free access to this content
    Poster Session 4: Stem Cell Biology; Varices and Bleeding

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1195A–1215A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28243

  8. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  9. You have free access to this content
    Review article: specifically targeted anti-viral therapy for hepatitis C – a new era in therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 1, July 2010, Pages: 14–28, C. M. Lange, C. Sarrazin and S. Zeuzem

    Version of Record online : 31 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04317.x

  10. You have free access to this content
    Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial

    Hepatology

    Volume 57, Issue 6, June 2013, Pages: 2143–2154, Mark S. Sulkowski, Tarik Asselah, Jacob Lalezari, Peter Ferenci, Hugo Fainboim, Barbara Leggett, Fernando Bessone, Stefan Mauss, Jeong Heo, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Scherer, Gerhard Nehmiz, Gerhard G. Steinmann and Wulf O. Böcher

    Version of Record online : 12 JUN 2013, DOI: 10.1002/hep.26276

  11. Role of Pegylated Interferon-α-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 5, November 2008, Pages: 573–580, LF Lopez-Cortes, B Valera-Bestard, A Gutierrez-Valencia, R Ruiz-Valderas, L Jimenez, A Arizcorreta, A Terrón and P Viciana

    Version of Record online : 2 JUL 2008, DOI: 10.1038/clpt.2008.110

  12. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  13. You have free access to this content
    2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients

    Therapeutic Apheresis and Dialysis

    Volume 16, Issue 4, August 2012, Pages: 289–310, Takashi Akiba, Kazuhiko Hora, Michio Imawari, Chifumi Sato, Eiji Tanaka, Namiki Izumi, Takashi Harada, Ryoichi Ando, Kan Kikuchi, Tadashi Tomo, Hideki Hirakata and Tadao Akizawa

    Version of Record online : 11 JUN 2012, DOI: 10.1111/j.1744-9987.2012.01078.x

  14. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22645

  15. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  16. Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 9, September 2010, Pages: 1498–1506, Hui Ma, Rui-feng Yang and Lai Wei

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1440-1746.2010.06282.x

  17. Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 11, Issue 2, March 2004, Pages: 157–165, R. Perrillo, K. D. Rothstein, R. Rubin, I. Alam, J. Imperial, G. Harb, S. Hu and W. Klaskala

    Version of Record online : 20 FEB 2004, DOI: 10.1046/j.1365-2893.2003.00482.x

  18. You have free access to this content
    Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection

    Hepatology Research

    Volume 47, Issue 3, March 2017, Pages: E142–E151, Shuhei Nishiguchi, Yasuhisa Urano, Keiko Suzaki, Atsushi Taniguchi, Joseph Scherer, Kristi L. Berger, Anne-Marie Quinson, Jerry O. Stern and Masao Omata

    Version of Record online : 10 AUG 2016, DOI: 10.1111/hepr.12741

  19. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  20. You have free access to this content
    AASLD Abstracts 1–219

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 309A–407A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22615